APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
64 hedge funds and large institutions have $85.8M invested in Aptose Biosciences, Inc. in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
32% less call options, than puts
Call options by funds: $251K | Put options by funds: $370K
42% less capital invested
Capital invested by funds: $148M → $85.8M (-$62.3M)
Holders
64
Holding in Top 10
1
Calls
$251K
Puts
$370K
Top Buyers
| 1 | +$2.01M | |
| 2 | +$1.94M | |
| 3 | +$1.58M | |
| 4 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$963K |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
+$907K |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$7.63M | |
| 3 | -$1.76M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$940K |
| 5 |
VC
Voss Capital
Houston,
Texas
|
-$768K |